CuraLife - Company Presentation - General

Preview:

Citation preview

“If we fail to give people with diabetes the long and healthylives we are capable of giving them, we will not be forgiven.”

Bill Clinton, US President, 1993-2001Keynote lecture at the ‘Global Changing Diabetes Leadership Forum’, New York, 2007

Natural Wellbeing Global

Our Vision

CuraLife is a nutritional supplement company that targets wellness and a healthier future for sufferers of chronic illness through natural, non-prescription remedies.

Our goal is to become a Category Champion in the mass market, consumer healthcare market for non-prescription, scientifically proven products.

Who Are We?

Trials and

usage show

efficacy and

quick results

Proven

A vision to

make the world

a better,

healthier place

Responsible

Increase

efficacy and

new products

in development

Innovative

Advisory board

with recognized

industry

professionals

Trusted

Exclusive rights

in major

markets with a

global

exclusive right

Global

R&D

Our advanced R&D facility, situated on London, combines knowledge of traditional ancient effective remedies together with modern research, extraction and development capabilities bringing best in class, safe and effective products.

Management Team

Rafi Elul

Chairman

Rafi is CEO of the strategic

consulting and ventures firm

ISHRA. He served two terms

in the national Parliament

and continues to advise the

offices of President and PM.

He is Chairman of the

national volunteer program

‘Ruach Tova’.

Ron Elul

Chief Executive Officer

Ron heads business

development activity with

successful track record

marketing and innovative

start-ups. He maintains

responsibility for project

design, development and

penetrating new markets

worldwide.

Ofer Yigdal

Chief Operating Officer

Ofer is responsible for key accounts,

service delivery and operational

efficiency. As an experienced

marketing professional, he has

worked with many of the major

health and wellness brands in Israel

and has experience of both channel

andproductmarketing.

CEO COOCHAIR VP

Henry Yahav

VP Sales & Marketing

Henry has been working in the

supplement industry for over 25

years. As former MD for Herbalife

Israel and Juice Plus. Henry also

has experience in the international

market with brands including NSA

Swiss, Morinda and is practiced at

developingrobust salesnetworks.

Advisory Board

Dr. Sara Kaplan

Dr. Sara Kaplan is a clinical dietitian

and leading diet expert. With over 30

years of working practice, she heads

Department of Human Nutrition and

Diet at Meuhedet, one of the Israel’s

largest private healthcare providers

and Nutritional Science at the Peres

Academic Center in Rehovot. She

holds a Ph.D in Clinical Epidemiology

from Tel-Aviv University.

Dr. Uri Eliyahu

Dr. Eliyahu has a Ph.D in Medical

Sciences specializing in

Epidemiology. As a licensed

pharmacist he holds an MSc in

Physiology and Pharmacology from

Tel Aviv University (cum laude). He is

Editor in Chief of the Israeli National

Pharmacist magazine and a leading

lecturer in many of Israel’s top

universities.

New Battleground – Consumer Healthcare

o A new consumer healthcare segment is emerging

o Healthcare products will move to the heart of the mass market

o Room to grow the brand + opportunity to exit

o Global prevalence of raised

cholesterol among adults (≥ 5.0

mmol/l) was 39% (2008).

o One third of ischaemic heart

disease is attributable to high

cholesterol.

o Estimated to cause 2.6 million

deaths (4.5% of total).

o 29.7 million (2%) of disability

adjusted life years (DALYS).

o A 10% reduction in serum

cholesterol in men aged 40 can

reduce heart disease by 50%

within 5 years.

o In high-income countries, over 50%

of adults had raised total

cholesterol.

Source: WHO estimates Global Health Observatory,

Pipeline – Large Addressable Markets

o 300 million asthma sufferers

worldwide.

o Number of asthmatics will grow by

more than 100 million by 2025.

o 250,000 annual deaths – almost all

are avoidable.

o 70% of asthmatics also have

allergies.

o World-wide, the economic costs

associated with asthma are

estimated to exceed those of TB

and HIV/AIDS combined.

Source: World Health Organization. Global

surveillance…,

o Globally, nearly one billion people

have high blood pressure

(hypertension).

o Raised blood pressure causes 7.5

million deaths (12.8% of total

deaths).

o Accounts for 57 million (3.7%)

disability adjusted life years

(DALYS).

o Blood pressure levels are shown to

be positively and continuously.

related to the risk for stroke and

coronary heart disease.

o Globally, raised blood pressure in

adults 25+ is around 40% (2008)

Source: WHO estimates Global Health Observatory,

World Heart Federation

Diabetes – the Basics

Source: http://www.idf.org/diabetesatlas/5e/the-global-burden

Diabetes – Impact on Body

A Global Epidemic

Source: http://www.idf.org/diabetesatlas/5e/the-global-burden

Diabetes Market Overview

In 2013, 382 million people were diagnosed

diabetics; by 2035 this will rise to 592 million.

183 million people (50%) with diabetes are

undiagnosed

Diabetes caused 4.6 million deaths in 2011

Diabetes caused at least $458 billion in

healthcare expenditure in 2013

11% of total healthcare expenditure in

adults (20-79 years)

$

2013

2035

382M

592M

Diabetes - Impact on Healthcare

o WHO estimates one patient with diabetes dies every 6 seconds

worldwide (2013) or 5.1 million deaths.

o Global health spending to treat diabetes and manage complications

totalled at least $548 billion in 2013.

o 76% of global health expenditure on diabetes in 2013 was for

people between the ages of 50 and 79 years.

o An estimated average of $1,437 per person with diabetes was spent

globally on treating and managing the disease in 2013.

o In high income countries spend was $5,621 per person compared

with $356 in low-middle income countries.

Source: http://www.idf.org/diabetesatlas/5e/the-global-burden

Product

Information

CuraLin - Product Efficacy

o Within 3-5 days users can expect to see a dramatic change in blood sugar

levels. After just one month we expect to see a significant reduction as well

as an improvement in the overall health of users.

o Results showed the product was successful in improving glycemic control in

patients.

o Recognizable ingredients with evidence of blood sugar reduction properties.

Patient Impacto The application of Ayurveda practice combined with the scientific knowledge of 21st

Century medicine creates a dramatic impact on the reduction of sugar levels produced in

the body.

o The formula reactivates and strengthens the pancreas which is responsible for the

production of insulin in the body.

o Blood sugar levels reduced with attention given to the overall balance of the body.

o Clear Benefits:

o Helps lower and control blood sugar levels

o Reactivates and strengthens the pancreas

o Helps with blurred vision

o Removes any tingling sensation

o Boosts energy levels

o Reduces dependency on allopathic medication

o Completely herbal

Customer Feedback (1)

A customer survey was conducted by phone in April 2014 with data

from an uncontrolled sample group of 50 product users.

o Average age 61

o Male 66% : Female 34%

o Average length of product use 3.1 years

o 44% take no other form of diabetic treatment

% reduction after 3 months

use

% reduction till today

Users 6 - 7.9 mmol/l 8.5% 10.7%

Users 8+ mmol/l 18.6% 24.4%

Total 13.3% 17.3%

Customer Feedback (2)

How satisfied are you with the

performance of the Supplement?

I am confident in my ability to manage my

blood sugar levels?

How big an impact has it had on your

lifestyle?Would you recommend the

supplement to anyone else?

Big

Impact

84%%

Some

Impact

14%

Neutral

2%

Confident

13%

Very

Confident

84%

Neutral

3%

Yes 100%

Very

Satisfied

94%

Satisfied

6%

Thank You – Ron Elul | +972 506 724 208 | ron@curalife.co

Recommended